Büller HR - Search Results

1

Di Nisio M, Middeldorp S, Büller HR. Di Nisio M, et al. Among authors: buller hr. N Engl J Med. 2005 Sep 8;353(10):1028-40. doi: 10.1056/NEJMra044440. N Engl J Med. 2005. PMID: 16148288 No abstract available.

2

The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders.

Meinardi JR, Middeldorp S, de Kam PJ, Koopman MM, van Pampus EC, Hamulyák K, Prins MH, Büller HR, van der Meer J. Meinardi JR, et al. Among authors: buller hr. Br J Haematol. 2002 Mar;116(3):625-31. doi: 10.1046/j.0007-1048.2001.03303.x. Br J Haematol. 2002. PMID: 11849222 Free article.

3

A rebuttal: Counseling pregnant women with factor V Leiden homozygosity: use absolute instead of relative risks.

Middeldorp S, van der Meer J, Hamulyák K, Büller HR. Middeldorp S, et al. Among authors: buller hr. Thromb Haemost. 2002 Feb;87(2):360-1; author reply 361. Thromb Haemost. 2002. PMID: 11858509 No abstract available.

4

Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin.

Bijsterveld NR, Moons AH, Meijers JC, Tijssen JG, Büller HR, Levi M, Peters RJ. Bijsterveld NR, et al. Among authors: buller hr. J Am Coll Cardiol. 2002 Mar 6;39(5):811-7. doi: 10.1016/s0735-1097(01)01825-3. J Am Coll Cardiol. 2002. PMID: 11869846 Free article. Clinical Trial.

5

Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.

Libourel EJ, Bank I, Meinardi JR, Baljé -Volkers CP, Hamulyak K, Middeldorp S, Koopman MM, van Pampus EC, Prins MH, Büller HR, van der Meer J. Libourel EJ, et al. Among authors: buller hr. Haematologica. 2002 Oct;87(10):1068-73. Haematologica. 2002. PMID: 12368162

6

High factor VIII plasma levels as a risk factor for venous thrombosis: no evidence of inheritance from a family cohort study.

Libourel EJ, Baljé-Volkers Degrees CP, Hamulyàk K, Prins MH, Middeldorp S, Büller HR, van der Meer J. Libourel EJ, et al. Among authors: buller hr. Haematologica. 2004 Jan;89(1):118-20. Haematologica. 2004. PMID: 14754621 No abstract available.

7

Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice.

Bank I, Scavenius MP, Büller HR, Middeldorp S. Bank I, et al. Among authors: buller hr. Thromb Res. 2004;113(1):7-12. doi: 10.1016/j.thromres.2004.02.002. Thromb Res. 2004. PMID: 15081560 Clinical Trial.

8

Antithrombotic therapy and cancer.

Di Nisio M, Squizzato A, Klerk CP, Richel DJ, Büller HR. Di Nisio M, et al. Among authors: buller hr. Curr Opin Hematol. 2004 May;11(3):187-91. doi: 10.1097/01.moh.0000130317.18163.83. Curr Opin Hematol. 2004. PMID: 15257019 Review.

9

Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.

Bank I, Libourel EJ, Middeldorp S, Van Pampus EC, Koopman MM, Hamulyák K, Prins MH, Van Der Meer J, Büller HR. Bank I, et al. Among authors: buller hr. Arch Intern Med. 2004 Sep 27;164(17):1932-7. doi: 10.1001/archinte.164.17.1932. Arch Intern Med. 2004. PMID: 15451770

10

Unselected women with elevated levels of factor VIII:C or homocysteine are not at increased risk for obstetric complications.

Middeldorp S, van de Poel MH, Bank I, Hamulyák K, Libourel EJ, Koopman MM, Prins MH, van der Meer J, Büller HR. Middeldorp S, et al. Among authors: buller hr. Thromb Haemost. 2004 Oct;92(4):787-90. doi: 10.1160/TH04-03-0198. Thromb Haemost. 2004. PMID: 15467909

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

733 results

Search Page